AMGEN INC.
NASDAQ: AMGN
▲
245.55
+2.25
+0.92%
1 Day
-
Open
243.25
-
Previous Close
243.30
-
Volume (Avg)
2.75M (3.65M)
-
Day's Range
240.72-246.00
-
52Wk Range
198.64-258.45
-
Market Cap.
131.17B
-
Dividend Rate (Yield)
7.76 (3.19%)
-
Beta
0.58
-
Shares Outstanding
534.20M
-
P/E Ratio (EPS)
23.95 (10.16)
Top Stories
-
Amgen's Beating the Market -- Here's Why It's a Buy Now
The Motley Fool 1 day ago -
2 Stocks That Could Survive the Next Recession
The Motley Fool -
Amgen Celebrates Pride Month In South San Francisco: Photo
Patch -
ReCode Therapeutics attracts $120 million in new investment for its drug delivery tech
Dallas Morning News -
Radius (RDUS), Menarini Submit NDA for Breast Cancer Drug
Zacks.com 6/23/2022 -
AbbVie (ABBV) Files Qulipta sNDA for Chronic Migraine Prevention
Zacks.com -
Holly Springs mulls LGBTQ protections as people rally in support of them. What they decided
The (Raleigh) News & Observer -
Merck reportedly eyeing acquisition of Seattle biotech giant Seagen
Geekwire -
1 Biotech Stock Giving Off a Healthy Yield
The Motley Fool -
Bayer, Amgen back ReCode's plan to broaden genetic medicine's reach
BioPharma Dive -
What You Need To Know About Amgen Inc.'s (NASDAQ:AMGN) Investor Composition
Yahoo -
Wealth Enhancement Advisory Services LLC Purchases Shares of 853 Amgen Inc. (NASDAQ:AMGN)
Defense World -
Amgen (NASDAQ:AMGN) Earns “Outperform” Rating from Oppenheimer
Defense World -
Peering Into Amgen's Recent Short Interest
Benzinga -
Amgen to sell Turkish unit Gensenta for $135M
Seeking Alpha 3 days agoAmgen (AMGN) has reached an agreement with Turkish pharmaceutical company Eczacıbaşı Group to sell 99.96% stake in its Istanbul-based unit Gensenta for $135M, Daily
-
Amgen Foundation Will Invest $30M on Open edX-Based LabXchange Platform
IBL News -
ReCode Therapeutics raises $120M in round co-led by Bayer, with participation from Amgen
Seeking Alpha -
From Tampa to Munich, Amgen’s ‘Places’ campaign introduces its locations around the world
ENDPOINTS NEWS
